M. Tabone

1.2k total citations
35 papers, 892 citations indexed

About

M. Tabone is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, M. Tabone has authored 35 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 21 papers in Epidemiology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in M. Tabone's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (13 papers) and Alcohol Consumption and Health Effects (12 papers). M. Tabone is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (13 papers) and Alcohol Consumption and Health Effects (12 papers). M. Tabone collaborates with scholars based in Italy, United States and Switzerland. M. Tabone's co-authors include Sarino Aricò, Emanuele Albano, Paolo Clot, Magnus Ingelman‐Sundberg, Giorgio Bellomo, G. Galatola, Alessandro Ferrero, A. Pera, Lorenzo Capussotti and Luca Viganò and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

M. Tabone

35 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Tabone Italy 17 443 421 337 130 126 35 892
Mutsumi Tsuchishima Japan 16 456 1.0× 241 0.6× 166 0.5× 41 0.3× 178 1.4× 50 797
Elisa Mottaran Italy 10 347 0.8× 131 0.3× 277 0.8× 32 0.2× 132 1.0× 12 614
Seiji Marubayashi Japan 14 148 0.3× 321 0.8× 205 0.6× 80 0.6× 159 1.3× 59 910
Shinji Iida Japan 12 252 0.6× 246 0.6× 110 0.3× 166 1.3× 179 1.4× 24 626
Nancy W. Bethea United States 13 174 0.4× 305 0.7× 59 0.2× 243 1.9× 151 1.2× 14 684
Manon Allaire France 15 495 1.1× 407 1.0× 80 0.2× 37 0.3× 191 1.5× 47 846
Svenja Sydor Germany 17 625 1.4× 279 0.7× 129 0.4× 53 0.4× 292 2.3× 38 1.0k
Tsutomu Yasutake Japan 17 460 1.0× 236 0.6× 159 0.5× 29 0.2× 355 2.8× 25 1.1k
M A Leo United States 16 346 0.8× 88 0.2× 467 1.4× 138 1.1× 339 2.7× 25 975
Stephen A. Borowsky United States 9 490 1.1× 148 0.4× 514 1.5× 111 0.9× 292 2.3× 12 1.1k

Countries citing papers authored by M. Tabone

Since Specialization
Citations

This map shows the geographic impact of M. Tabone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tabone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tabone more than expected).

Fields of papers citing papers by M. Tabone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Tabone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tabone. The network helps show where M. Tabone may publish in the future.

Co-authorship network of co-authors of M. Tabone

This figure shows the co-authorship network connecting the top 25 collaborators of M. Tabone. A scholar is included among the top collaborators of M. Tabone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Tabone. M. Tabone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carucci, P., Silvia Gaia, Emanuela Rolle, et al.. (2021). Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis. Journal of Digestive Diseases. 22(8). 496–502. 12 indexed citations
2.
Tabone, M., Nadia Russolillo, Serena Langella, et al.. (2020). Downstaging unresectable hepatocellular carcinoma by radioembolization using 90-yttrium resin microspheres: a single center experience. Journal of Gastrointestinal Oncology. 11(1). 84–90. 22 indexed citations
3.
Bonardi, R, et al.. (2011). Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin. Biomedicine & Pharmacotherapy. 65(4). 303–306. 5 indexed citations
4.
Capussotti, Lorenzo, Alessandro Ferrero, Luca Viganò, Roberto Polastri, & M. Tabone. (2007). Liver resection for HCC with cirrhosis: Surgical perspectives out of EASL/AASLD guidelines. European Journal of Surgical Oncology. 35(1). 11–15. 47 indexed citations
5.
Tabone, M., et al.. (2006). Prevention of intrahepatic recurrence by adjuvant 131iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis. European Journal of Surgical Oncology. 33(1). 61–66. 26 indexed citations
6.
Mangia, Alessandra, Gioacchino Leandro, Beat Helbling, et al.. (2003). Combination therapy with amantadine and interferon in naıve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials. Journal of Hepatology. 40(3). 478–483. 30 indexed citations
7.
Saracco, Giorgio Maria, Alessia Ciancio, S. Carenzi, et al.. (2002). A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy. Hepatology. 36(4). 959–966. 23 indexed citations
8.
Pellicano, Rinaldo, Giuseppe Cariti, M. Tabone, et al.. (2002). Re-treatment with interferon-beta of patients with chronic hepatitis C virus infection. European Journal of Gastroenterology & Hepatology. 14(12). 1377–1382. 9 indexed citations
9.
Tabone, M., C. Laudi, Salvatore Pellegrino, et al.. (2002). Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy. Journal of Viral Hepatitis. 9(4). 288–294. 44 indexed citations
10.
Tabone, M., C. Laudi, A Biglino, et al.. (2001). Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients. Journal of Hepatology. 35(4). 517–521. 31 indexed citations
11.
Saracco, Giorgio Maria, Valeria Ghisetti, Giuseppe Cariti, et al.. (2001). Treatment with interferon-α2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. European Journal of Gastroenterology & Hepatology. 13(2). 149–155. 2 indexed citations
12.
Fracchia, M., et al.. (2000). Serum interferon gamma in primary biliary cirrhosis. European Journal of Gastroenterology & Hepatology. 12(4). 463–468. 8 indexed citations
13.
Tabone, M., R Bonardi, Stefano Taraglio, et al.. (1997). Pre-treatment levels of anti-HCV core IgM antibodies are closely associated with response to alpha interferon therapy in chronic hepatitis C patients. European Journal of Gastroenterology & Hepatology. 9(3). 287–291. 7 indexed citations
14.
Clot, Paolo, Maurizio Parola, Giorgio Bellomo, et al.. (1997). Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology. 113(1). 265–276. 65 indexed citations
15.
Clot, Paolo, Emanuele Albano, Erik Eliasson, et al.. (1996). Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics. Gastroenterology. 111(1). 206–216. 78 indexed citations
16.
Aricò, Sarino, G. Galatola, M. Tabone, et al.. (1995). The measure of life‐time alcohol consumption in patients with cirrhosis: reproducibility and clinical relevance. Liver International. 15(4). 202–208. 19 indexed citations
17.
Clot, Paolo, Giorgio Bellomo, M. Tabone, Sarino Aricò, & Emanuele Albano. (1995). Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology. 108(1). 201–207. 84 indexed citations
18.
Tabone, M., et al.. (1994). Serum levels of anti‐hepatitis C virus IgM core antibodies may predict the response to interferon‐α therapy in chronic hepatitis C. Journal of Viral Hepatitis. 1(2). 155–157. 5 indexed citations
19.
Aricò, Sarino, Giovanni Corrao, Alessandro Federico, et al.. (1994). A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients. European Journal of Epidemiology. 10(3). 251–257. 15 indexed citations
20.
Rizzetto, Mario, et al.. (1991). [Intrahepatic cholestasis in hyperthyroidism].. PubMed. 82(6). 319–23. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mutsumi Tsuchishima Breakdown of academic impact, for papers by Elisa Mottaran Breakdown of academic impact, for papers by Seiji Marubayashi Breakdown of academic impact, for papers by Shinji Iida Breakdown of academic impact, for papers by Nancy W. Bethea Breakdown of academic impact, for papers by Manon Allaire Breakdown of academic impact, for papers by Svenja Sydor Breakdown of academic impact, for papers by Tsutomu Yasutake Breakdown of academic impact, for papers by M A Leo Breakdown of academic impact, for papers by Stephen A. Borowsky
Rankless by CCL
2026